“An environmental screen should be part of every wellness check.”
@mirandacspencer.bsky.social
@mirandacspencer.bsky.social
@75338.bsky.social
@gmj-georgia.bsky.socialThe obesity drug industry is shifting gears. Instead of chasing maximum weight loss, developers now prioritize tolerability and patient persistence—recog… #Clinicaltrials #Drugdevelopment #Obesity #Pharmacotherapy #Tolerability #Clinicaltrials #Drugdevelopment #Obesity #Pharmacotherapy #Tolerab…
@bigearthdata.ai
@sabienpadilla.bsky.socialI'm sure you have all heard the saying, "What goes around comes around." Well, have you had a look around out there lately, folks?!
😳😲🥴🤢🤮🧟♀️🧟♂️🪦👹💩
@jamanetworkopen.com📈 In middle-aged adults with #Obesity, 4 weeks of urolithin A did not improve peripheral #EndothelialFunction vs placebo, but task-evoked #CerebrovascularFunction responses increased. ja.ma/4hWXM1A
@pharmalot.bsky.social
@jinternmed.bsky.socialNew review! #GLP-1 receptor agonists and serious adverse events.
➡️ Appraises evidence regarding seven serious adverse events linked to GLP-1 receptor agonists.
➡️ Evidence, uncertainty and clinical implications.
@thelancetendo.bsky.socialSten Madsbad & Jens J Holst comment on:
#Petrelintide and the evolving role of #amylin agonism in #obesity thelancet.com/journals/lan...
#FREE to read w/reg (also FREE)
@thelancetendo.bsky.social#Petrelintide is a novel, long-acting #amylin analogue being developed for long-term treatment of #obesity, leveraging a mechanism of action distinct from incretin-based treatments thelancet.com/journals/lan...
#FREE to read w/reg (also FREE)
@500ways.bsky.socialSee this short article about the unfortunate weight penalty. It's free and complete at worlds-worst-website.com/worst-weight... ( #overweight, #heavyset, #obese, #obesity, #hefty, #workforce, #officePolitics, #hiring, #hiringPractices, #discrimination, #weightDiscrimination)
@epigenometech.bsky.socialEpigenetics Update - Maternal obesity imprints methylation marks in oocytes to drive intergenerational metabolic dysfunction www.nature.com/articles/s42...
#Epigenetics #DNAm #Obesity #Metabolism #Oocytes
---
Discover the breakthrough at epigenometech.com
@canadahealthwatch.caWHO says no obesity drugs, surgery for under-10s, AFP reports. Read more at canadahealthwatch.ca #CdnHealth #Obesity
@wileyhealth.bsky.socialDiscover impactful research from #Obesity, featuring insights shaping the future of obesity care.
#ObesityEditorsChoice
#October2026
Read Now >> https://bit.ly/4zlrTqr
@imsepidemiology.bsky.social3/ The session brought together expert perspectives from Dr Julia Mueller (Chair), Professor Alex Miras, Dr Alex Griffiths and Dr Rebecca Jones, highlighting the importance of a holistic, person-centred approach to obesity care. #UKCO2026 #Obesity #WeightManagement #GLP1
@midgardfinance.com💉 #pharma #obesity #petrelintide $ZEAL 🇩🇰 $RO 🇨🇭
Petrelintide in type 2 diabetes: 7.4-9.2% weight loss at week 28 vs 2.0% on placebo (#ZUPREME-2, Phase 2, 220 people).
Without diabetes: 7.9-9.8% at the same week. HbA1c fell by up to 0.65 points.
midgardfinance.com/obesity/drugs/petrelintide/
@healthcaretoday.bsky.socialProf Paul Gately, chief executive of Obesity UK and MoreLife, argues that current care pathways, policy frameworks and funding of resources have not kept up with how obesity is managed.
@jamanetworkopen.com📈 Among US adults eligible for obesity treatment, oral #Semaglutide uptake increased rapidly after approval for #Obesity and approached injectable semaglutide within 3 months. More than half of initiators had no prior semaglutide use.
@therealfloodguy.bsky.social
@toppnews.bsky.social